NALIRIFOX
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for NALIRIFOX, covering 2024-04-03 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma [Phase 2]